文献速递生殖医学

经非整倍体植入前遗传学检测识别的嵌合体胚胎移植后的新生儿与临床结局

Neonatal and clinical outcomes after transfer of a mosaic embryo identified by preimplantation genetic testing for aneuploidies.
PubMed 文献 · Reprod Biomed Online · 2022-01-31

本回顾性队列研究比较了513枚整倍体胚胎与118枚嵌合体胚胎(72枚全染色体嵌合、40枚节段性嵌合、6枚复杂嵌合)移植后的种植率、活产率及流产率。整倍体胚胎移植的种植率(47.0%)和活产率(40.7%)显著高于嵌合体胚胎(种植率39.0%,P=0.005;活产率28.8%,P=0.008)及全染色体嵌合胚胎(种植率37.5%,P=0.01;活产率22.2%,P=0.007)。节段性嵌合胚胎的种植率(47.5%)和活产率(45.0%)与整倍体胚胎相当。非整倍体细胞比例高(≥60%)的嵌合胚胎活产率显著低于整倍体胚胎(10.5% vs 40.7%,P=0.03)。两组新生儿结局无显著差异。

要点

  • 整倍体胚胎移植的种植率和活产率显著高于嵌合体及全染色体嵌合胚胎。
  • 节段性嵌合胚胎的种植率和活产率与整倍体胚胎相当。
  • 非整倍体细胞比例≥60%的嵌合胚胎活产率显著降低,作者建议赋予低移植优先级。

核心结论

  • 嵌合体胚胎与较低的活产率相关,而节段性嵌合胚胎的临床结局与整倍体胚胎相似。
  • 非整倍体比例高(≥60%)的嵌合胚胎应赋予低移植优先级。
  • 整倍体组与嵌合体组的新生儿结局无显著差异。

研究设计与样本

  • 回顾性队列研究,比较513枚整倍体胚胎与118枚嵌合体胚胎(72枚全染色体嵌合、40枚节段性嵌合、6枚复杂嵌合)的移植结局。
  • 胚胎经非整倍体植入前遗传学检测结合下一代测序分析,随后行单枚玻璃化冻融胚胎移植。
  • 滋养层活检中异常细胞比例20-80%定义为嵌合体。

主要发现

  • 协变量调整后,整倍体胚胎移植的种植率(47.0%)显著高于嵌合体胚胎(39.0%,P=0.005)和全染色体嵌合胚胎(37.5%,P=0.01)。
  • 协变量调整后,整倍体胚胎移植的活产率(40.7%)显著高于嵌合体胚胎(28.8%,P=0.008)和全染色体嵌合胚胎(22.2%,P=0.007)。
  • 节段性嵌合胚胎的种植率(47.5%)和活产率(45.0%)与整倍体胚胎相当。
  • 协变量调整后,非整倍体细胞比例≥60%的嵌合胚胎活产率(10.5%)显著低于整倍体胚胎(40.7%,P=0.03),且5例种植中有3例流产。
  • 嵌合体组与整倍体组的新生儿结局无显著差异;34例嵌合体胚胎移植后活产妇女中13例有产前或产后遗传学检测结果,未发现异常。

临床怎么用

  • 作者认为,非整倍体比例高(≥60%)的嵌合胚胎应赋予低移植优先级。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Do clinical and neonatal outcomes differ between mosaic embryo transfers (MET) and euploid embryo transfers (EET)? DESIGN: This retrospective cohort study compared the implantation rate, live birth rate (LBR) and miscarriage rate between 513 euploid embryos and 118 mosaic embryos (72 whole chromosome mosaic [WCM], 40 segmental mosaic and six complex mosaic). Blastocysts were analysed using preimplantation genetic testing for aneuploidies with next-generation sequencing, followed by a single vitrified-warmed embryo transfer. Trophectoderm biopsies were classified as mosaic if they had 20-80% abnormal cells. RESULTS: Overall, EET resulted in a significantly higher implantation rate (47.0%) and LBR (40.7%) than MET (implantation rate 39.0%, P = 0.005; LBR 28.8%, P = 0.008) and WCM embryos (implantation rate 37.5%, P = 0.01; LBR 22.2%, P = 0.007) after covariate adjustment. Segmental mosaic embryos had an implantation rate (47.5%) and LBR (45.0%) comparable to those of euploid embryos. Mosaic embryos with a high percentage of aneuploid cells (≥60%) showed a significantly lower LBR (10.5% versus 40.7%, P = 0.03) than euploid embryos after covariate adjustment, with three of the five implantations of mosaic embryos resulting in miscarriage. Neonatal outcomes did not differ significantly between the mosaic and euploid groups. Of the 34 women with a live birth after MET, 13 had a prenatal or postnatal genetic testing result, and no abnormalities were found. CONCLUSIONS: Mosaic embryos were associated with a lower LBR, while segmental mosaic embryos had similar clinical outcomes to euploid embryos. Mosaic embryos with a high aneuploidy percentage (≥60%) should be assigned a low transfer priority. Neonatal outcomes did not differ significantly between the euploid and mosaic groups.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Yakovlev P, Vyatkina S, Polyakov A, et al. Neonatal and clinical outcomes after transfer of a mosaic embryo identified by preimplantation genetic testing for aneuploidies. Reprod Biomed Online. 2022. PMID: 35469763. doi:10.1016/j.rbmo.2022.01.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。